Home / Health / The activated form of vitamin D may reduce the risk of COVID-19 severity, says a Spanish study

The activated form of vitamin D may reduce the risk of COVID-19 severity, says a Spanish study



A new study conducted in Spain has shown that high doses of calcifediol, the activated form of vitamin D, can significantly reduce the risk of intensive care treatment of COVID-19 patients.

The findings emerged as scientists search for an inexpensive antiviral drug that can treat patients with severe COVID-19 infection.

I study


The Spanish study published in ScienceDirect was conducted on 50-76 patients hospitalized with COVID-19. These patients were treated with calcifediol and only one of these patients required admission to the ICU. The rest of the patients were discharged without complications.

People who did not receive the drug, some of them were admitted to intensive care and two died. “Our pilot study showed that administration of a high dose of calcifediol or 25-hydroxyvitamin D, the major metabolite of the endocrine system of vitamin D, significantly reduced the need for ICU treatment for patients requiring hospitalization. because of the proven Covid-1

9, “said Marta Entrenas Castillo of the ReinaSof√≠a University Hospital in Cordoba, the lead author of the study report.

Calcifediol has been shown to be able to reduce the risk of severe COVID infection, although more large group studies are needed to establish a definitive response.


Source link